These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 36700425)
1. Absorption, distribution, metabolism and excretion of Ma J; Ye Q; Northcutt V; Babiak J; Kong R Xenobiotica; 2022 Dec; 52(12):1031-1040. PubMed ID: 36700425 [TBL] [Abstract][Full Text] [Related]
2. Ma J; Laskin OL; Roffel AF; Vaes WHJ; Tang B; Kolnaar J; O'Keefe K; Golden L; Kong R Drug Metab Dispos; 2023 Oct; ():. PubMed ID: 37852795 [TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism, pharmacokinetics and drug interaction potentials of emvododstat, a DHODH inhibitor. Ma J; Kaushik D; Yeh S; Northcutt V; Babiak J; Risher N; Weetall M; Moon YC; Welch EM; Molony L; O'Keefe K; Kong R Xenobiotica; 2022 Feb; 52(2):152-164. PubMed ID: 34846990 [TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution, metabolism and excretion of Ma J; Lee L; Yao B; Giannousis P; Thoolen M; Ye Q; Golden L; Klein M; Kong R Xenobiotica; 2023 May; 53(5):396-411. PubMed ID: 37552765 [TBL] [Abstract][Full Text] [Related]
5. Absorption, distribution, metabolism, and excretion of [¹⁴C]GDC-0449 (vismodegib), an orally active hedgehog pathway inhibitor, in rats and dogs: a unique metabolic pathway via pyridine ring opening. Yue Q; Chen YH; Mulder T; Deese A; Takahashi R; Rudewicz PJ; Reynolds M; Solon E; Hop CE; Wong H; Khojasteh SC Drug Metab Dispos; 2011 Jun; 39(6):952-65. PubMed ID: 21363998 [TBL] [Abstract][Full Text] [Related]
6. Absorption, distribution, metabolism, and excretion of mTOR kinase inhibitor CC-223 in rats, dogs, and humans. Tong Z; Atsriku C; Yerramilli U; Wang X; Nissel J; Li Y; Surapaneni S Xenobiotica; 2019 Jan; 49(1):43-53. PubMed ID: 29206565 [TBL] [Abstract][Full Text] [Related]
7. A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitor. Morton TL; Laskin OL; Kaushik D; Lee L; Ma J; Bar CM; Kristensen A; O'Keefe K; Golden L; Klein M; Kong R Eur J Clin Pharmacol; 2023 Aug; 79(8):1073-1080. PubMed ID: 37278823 [TBL] [Abstract][Full Text] [Related]
8. Absorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent Ma S; Cho S; Sahasranaman S; Zhao W; Pang J; Ding X; Dean B; Wang B; Hsu JY; Ware J; Salphati L Drug Metab Dispos; 2023 Apr; 51(4):436-450. PubMed ID: 36623882 [TBL] [Abstract][Full Text] [Related]
9. A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti-SARS-CoV-2 (COVID-19) DHODH (dihydroorotate dehydrogenase) inhibitor. Morton TL; Laskin OL; Kaushik D; Lee L; Ma J; Kristensen A; O'Keefe K; Golden L; Klein M; Kong R Pharmacol Res Perspect; 2023 Apr; 11(2):e01076. PubMed ID: 36938928 [TBL] [Abstract][Full Text] [Related]
10. Absorption, Distribution, Metabolism, and Excretion of [ Yang C; Xue M; He Y; Yin H; Yang C; Zhong D; Zeng H; Zheng Y; Diao X Molecules; 2023 Dec; 28(24):. PubMed ID: 38138590 [TBL] [Abstract][Full Text] [Related]
11. Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia. Branstrom A; Cao L; Furia B; Trotta C; Santaguida M; Graci JD; Colacino JM; Ray B; Li W; Sheedy J; Mollin A; Yeh S; Kong R; Sheridan R; Baird JD; O'Keefe K; Spiegel R; Goodwin E; Keating S; Weetall M Front Oncol; 2022; 12():832816. PubMed ID: 35223511 [TBL] [Abstract][Full Text] [Related]
12. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
13. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Prakash C; Soliman V Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-alpha] [1,4] benzodiazepine, triazolam, a new central depressant. I. Absorption, distribution and excretion in rats, dogs and monkeys. Kitagawa H; Esumi Y; Kurosawa S; Sekine S; Yokoshima T Xenobiotica; 1979 Jul; 9(7):415-28. PubMed ID: 40350 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, metabolism, and excretion of licogliflozin, a dual inhibitor of SGLT1/2, in rats, dogs, and humans. Wang-Lakshman L; Mendonza AE; Huber R; Walles M; He Y; Jarugula V Xenobiotica; 2021 Apr; 51(4):413-426. PubMed ID: 33413022 [TBL] [Abstract][Full Text] [Related]
17. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and mass balance of vericiguat in rats and dogs and distribution in rats. Janssen W; Schwarz T; Bütehorn U; Steinke W; Sandmann S; Lang D; Kern A; Hucke F; Gerisch M Xenobiotica; 2022 May; 52(5):453-462. PubMed ID: 35616579 [TBL] [Abstract][Full Text] [Related]
19. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs. Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]